Sign in
CompletedNo phase

HyperArc Registry Study

Key facts

Who runs it
Varian, a Siemens Healthineers Company
Where
Birmingham, United StatesSee the siteAlso in 3 other countries, 6 sites
Trial code
Status
Completed
People taking part
968 people enrolled
Started
31 Mar 2022
Ended
31 Mar 2025
Type of study
Observational
Treatments tested
  • Stereotactic radiosurgery
Record updated
24 September 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Received or scheduled to receive treatment using the HyperArc treatment method
  • Age of legal adult according to local law
  • Signed informed consent form, or, informed consent waived by the local ethics board/institutional review board

Who cannot take part

  • None, apart from not meeting Inclusion Criteria

Where in United States

Also in 3 other countries, 6 sites

  • University of AlabamaBirmingham, United States

About the trial

What the trial wants to find out

The HyperArc registry is designed to collect data from which the efficacy of the HyperArc procedure can be assessed and compared to alternative treatments.

Treatments tested

  • Stereotactic radiosurgery

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
24 September 2025